News

Orexo launches digital therapies for depression, alcohol misuse early in US

https://pharmaphorum.com/news/orexo-launches-digital-therapies-for-depression-alcohol-misuse-early-in-us/

FDA grants fast review for Bayer/Merck & Co’s heart failure drug

https://pharmaphorum.com/news/fda-grants-fast-review-for-bayer-merck-cos-heart-failure-drug/

Teva launches digital asthma and COPD rescue inhaler in US

https://pharmaphorum.com/news/fda-approves-tevas-digital-asthma-and-copd-rescue-inhaler/

https://pharmaphorum.com/news/nice-backs-nhs-use-for-astellas-xospata-after-rethink/

UK patients get early access to Alnylam’s ultra-rare disease drug lumasiran

https://pharmaphorum.com/news/uk-patients-get-early-access-to-alnylams-ultra-rare-disease-drug-lumasiran/

Mallinckrodt’s liver disease drug terlipressin edges FDA advisory panel

https://pharmaphorum.com/news/mallinckrodts-liver-disease-drug-terlipressin-edges-fda-advisory-panel/

COVID-19 has been a digital “accelerant” for healthcare firms; report

https://pharmaphorum.com/news/covid-19-has-been-a-digital-accelerant-for-healthcare-firms-report/

GSK-partnered Medicago starts trials of plant-based COVID-19 vaccine

https://pharmaphorum.com/news/gsk-partnered-medicago-starts-trials-of-plant-based-covid-19-vaccine/

FDA experts okay GSK’s multiple myeloma drug despite safety worries

https://pharmaphorum.com/news/fda-experts-okay-gsks-multiple-myeloma-drug-despite-safety-worries/

Close in 10 seconds

Pharmaphorum.com

Search